Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.
about
Involvement of beta-chemokines in the development of inflammatory demyelinationActions of Thyroid Hormone Analogues on ChemokinesPlasma biomarkers discriminate clinical forms of multiple sclerosisPermeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosisThe blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targetingFeasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosisAn investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians.Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.Targeting monocyte chemoattractant protein-1 signalling in disease.The meninges: new therapeutic targets for multiple sclerosis.Optic neuritis: chemokine receptor CXCR3 and its ligands.Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10.CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro.Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.Prenatal fat-rich diet exposure alters responses of embryonic neurons to the chemokine, CCL2, in the hypothalamus.Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS.Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14(+) monocytes in frail older adults.Increased Intrathecal Chemokine Receptor CCR2 Expression in Multiple Sclerosis.Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis.Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse.Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome.Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse.Multiple sclerosis: a study of chemokine receptors and regulatory T cells in relation to MRI variables.Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS.Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis
P2860
Q24801279-77D7332E-DDD7-46AC-B5AB-B55C66459930Q26738767-4E85BF4B-7148-4420-9817-5DD65722A7A0Q28262774-377906B3-C345-4E9E-B573-132A996EE902Q28265269-BBAE06FC-FBF6-4402-AF45-167E991FBA2BQ28299076-717E6833-2899-43D6-85FC-83F4049593FEQ28535303-33CC7756-4EE9-4E3B-9C19-28107994A0EFQ33252011-4ABC8B2E-799B-468C-9256-F3B156A1A873Q34700673-989642FC-505B-4CA9-9A2B-B5920DCEFF2AQ35056023-280DD202-0964-49F6-9F4A-31C5696F06B5Q35584727-6D6804A9-3DF8-4459-8163-D605517F42C6Q35592401-45C8E5BE-B86F-4117-BB80-9C9F795A8598Q35648177-981DBAF7-68FB-46BD-A752-68594F9687D2Q36497113-042ED89E-A076-4512-A8CA-DA803B170C93Q36734084-359E0F6B-07BF-4C86-A365-FAAEA1BC7246Q36818315-53E6C262-1629-4CBC-B376-D4AAAAD097D4Q36884649-305E14BD-494A-4B7C-AC9E-4D24895A1C3FQ37170178-F8D86F29-5190-4404-89E2-DE9433F28D15Q37281001-0E1FAE3C-8C11-4F12-82CC-749AF3ECBF34Q40551833-1CD69001-BA05-4B76-80B0-CAE012C039CCQ44412466-D19BE771-380A-433B-9979-EEE4E6E3086DQ45077383-32211B2E-3360-448A-991B-07BAC414E3C4Q45154866-B81109ED-D053-4DDE-8181-111B551A0212Q48217249-41AA9051-F446-41A5-A448-FC373DE3C169Q48325664-E9EA831B-B6A5-48BF-A9C4-0DC150D78FEEQ48726201-0BE56A35-BEA9-4E0E-862C-1A1FFD2AA813Q58857634-5F431FFD-D475-4A29-8697-441640B4A33B
P2860
Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Chemokines CXCL10 and CCL2: di ...... mmation in multiple sclerosis.
@en
Chemokines CXCL10 and CCL2: di ...... mmation in multiple sclerosis.
@nl
type
label
Chemokines CXCL10 and CCL2: di ...... mmation in multiple sclerosis.
@en
Chemokines CXCL10 and CCL2: di ...... mmation in multiple sclerosis.
@nl
prefLabel
Chemokines CXCL10 and CCL2: di ...... mmation in multiple sclerosis.
@en
Chemokines CXCL10 and CCL2: di ...... mmation in multiple sclerosis.
@nl
P2093
P2860
P1476
Chemokines CXCL10 and CCL2: di ...... ammation in multiple sclerosis
@en
P2093
C V Jensen
R M Ransohoff
R M Strieter
T L Sørensen
P2860
P304
P356
10.1046/J.1468-1331.2001.00327.X
P577
2001-11-01T00:00:00Z